Autnami 2,5 mg/850 mg filmom obložene tablete
| Name | Autnami 2,5 mg/850 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-553700118 |
| Active Substance | linagliptin metforminklorid |
| Composition | jedna tableta sadrži 2,5 mg linagliptina i 850 mg metforminklorida |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija PharOS MT Ltd, Birzebbugia, Malta Pharos Pharmaceutical Oriented Services Ltd., Metamorfossi Attikis, Grčka |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 27.09.2024 |
| MA Period of Validity | 27.09.2029 |
| Classification Number | UP/I-530-09/23-01/185 |
| Registration Number | 381-12-01/70-24-09 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BD11 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
